Ultrasound agent ready for sale in Europe:
This article was originally published in Clinica
Mallinckrodt and Molecular Biosystems will begin selling its ultrasound cardiac imaging agent, Optison, in Germany, Austria and the UK immediately, following European approval. The agent, which is already sold in the US, will be launched in other European countries when pricing approvals are granted.
You may also be interested in...
The Mallorca-based biotech is building a strong data package for SNF472 which the company believes will be an effective treatment for a number of calcification disorders in dialysis patients.
India’s Sun Pharma has been denied leave to appeal against a US court decision rejecting the company’s bid for dismissal of a multi-district antitrust lawsuit.
Former Sandoz executive Hector Armando Kellum has admitted involvement in a US generic price-fixing conspiracy, the US Department of Justice has announced.